BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 21055929)

  • 21. Synthesis, anti-inflammatory activity, and in vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones.
    Harrak Y; Casula G; Basset J; Rosell G; Plescia S; Raffa D; Cusimano MG; Pouplana R; Pujol MD
    J Med Chem; 2010 Sep; 53(18):6560-71. PubMed ID: 20804197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New cyclooxygenase-2/5-lipoxygenase inhibitors. 2. 7-tert-butyl-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations of the dihydrobenzofuran ring.
    Janusz JM; Young PA; Scherz MW; Enzweiler K; Wu LI; Gan L; Pikul S; McDow-Dunham KL; Johnson CR; Senanayake CB; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
    J Med Chem; 1998 Mar; 41(7):1124-37. PubMed ID: 9544212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
    Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
    Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivatives.
    Hernández P; Cabrera M; Lavaggi ML; Celano L; Tiscornia I; Rodrigues da Costa T; Thomson L; Bollati-Fogolín M; Miranda AL; Lima LM; Barreiro EJ; González M; Cerecetto H
    Bioorg Med Chem; 2012 Mar; 20(6):2158-71. PubMed ID: 22356737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
    Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
    El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM
    Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and biological evaluation of (E)-3-(4-methanesulfonylphenyl)-2-(aryl)acrylic acids as dual inhibitors of cyclooxygenases and lipoxygenases.
    Moreau A; Chen QH; Praveen Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7716-27. PubMed ID: 16931030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient synthesis and 5-LOX/COX-inhibitory activity of some 3-hydroxybenzo[b]thiophene-2-carboxylic acid derivatives.
    Hansen FK; Khankischpur M; Tolaymat I; Mesaros R; Dannhardt G; Geffken D
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5031-4. PubMed ID: 22749420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.
    Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Chen J; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
    J Med Chem; 1998 Aug; 41(18):3515-29. PubMed ID: 9719605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX.
    Huang Y; Zhang B; Li J; Liu H; Zhang Y; Yang Z; Liu W
    Eur J Med Chem; 2019 Oct; 180():41-50. PubMed ID: 31299586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigations of new pyridazinone derivatives for the synthesis of potent analgesic and anti-inflammatory compounds with cyclooxygenase inhibitory activity.
    Okçelik B; Unlü S; Banoglu E; Küpeli E; Yeşilada E; Sahin MF
    Arch Pharm (Weinheim); 2003 Sep; 336(9):406-12. PubMed ID: 14528488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.
    Hofmann B; Barzen S; Rödl CB; Kiehl A; Borig J; Zivković A; Stark H; Schneider G; Steinhilber D
    J Med Chem; 2011 Mar; 54(6):1943-7. PubMed ID: 21341744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, anti-inflammatory activity and molecular docking studies of 2,5-diarylfuran amino acid derivatives.
    Stefani HA; Botteselle GV; Zukerman-Schpector J; Caracelli I; da Silva Corrêa D; Farsky SH; Machado ID; Santin JR; Hebeda CB
    Eur J Med Chem; 2012 Jan; 47(1):52-8. PubMed ID: 22071254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; design, synthesis and biological evaluation as potential anti-inflammatory agents.
    Abdelazeem AH; Abdelatef SA; El-Saadi MT; Omar HA; Khan SI; McCurdy CR; El-Moghazy SM
    Eur J Pharm Sci; 2014 Oct; 62():197-211. PubMed ID: 24907682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and anti-ulcerogenic effect of some of furo-salicylic acid derivatives on acetic acid-induced ulcerative colitis.
    Hassan GS; Soliman GA
    Eur J Med Chem; 2010 Sep; 45(9):4104-12. PubMed ID: 20573425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indole based peptidomimetics as anti-inflammatory and anti-hyperalgesic agents: Dual inhibition of 5-LOX and COX-2 enzymes.
    Singh P; Prasher P; Dhillon P; Bhatti R
    Eur J Med Chem; 2015 Jun; 97():104-23. PubMed ID: 25956953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies.
    Abdelgawad MA; Labib MB; Ali WAM; Kamel G; Azouz AA; El-Nahass ES
    Bioorg Chem; 2018 Aug; 78():103-114. PubMed ID: 29550530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides.
    Lin SJ; Tsai WJ; Chiou WF; Yang TH; Yang LM
    Bioorg Med Chem; 2008 Mar; 16(5):2697-706. PubMed ID: 18063374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
    Zarghi A; Ghodsi R
    Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.